Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia
暂无分享,去创建一个
Tannishtha Reya | P. Beachy | Annelie Abrahamsson | T. Reya | Chen Zhao | Alan Chen | C. Jamieson | M. Fereshteh | Jordan M. Blum | H. Kwon | Jynho Kim | J. Chute | D. Rizzieri | M. Munchhof | T. Vanarsdale | Philip A. Beachy | Annelie Abrahamsson | David Rizzieri | Hyog Young Kwon | Jordan Blum | Chen Zhao | John P. Chute | Alan Chen | Catriona H. Jamieson | Mark Fereshteh | Jynho Kim | Michael Munchhof | Todd VanArsdale
[1] P. Ingham,et al. Orchestrating ontogenesis: variations on a theme by sonic hedgehog , 2006, Nature Reviews Genetics.
[2] Aleksandar Dakic,et al. Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells , 2007, Science.
[3] Keith L Ligon,et al. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. , 2006, Cancer research.
[4] Jussi Taipale,et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. , 2002, Genes & development.
[5] A. McMahon,et al. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. , 2001, Development.
[6] R. Myers,et al. Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome , 1996, Science.
[7] M. Scott,et al. Altered neural cell fates and medulloblastoma in mouse patched mutants. , 1997, Science.
[8] Marie Evangelista,et al. The Hedgehog Signaling Pathway in Cancer , 2006, Clinical Cancer Research.
[9] T. Reya,et al. Loss of b-Catenin Impairs the Renewal of Normal and CML Stem Cells In Vivo , 2022 .
[10] M. Scott,et al. Patching the gaps in Hedgehog signalling , 2007, Nature Cell Biology.
[11] G. Fishell,et al. Mosaic Removal of Hedgehog Signaling in the Adult SVZ Reveals That the Residual Wild-Type Stem Cells Have a Limited Capacity for Self-Renewal , 2007, The Journal of Neuroscience.
[12] T. Holyoake,et al. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. , 2002, Blood.
[13] B. Druker,et al. Targeted CML therapy: controlling drug resistance, seeking cure. , 2006, Current opinion in genetics & development.
[14] J. Taipale,et al. The Hedgehog and Wnt signalling pathways in cancer , 2001, Nature.
[15] R. Ren,et al. Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia , 2005, Nature Reviews Cancer.
[16] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[17] J. García-Verdugo,et al. Hedgehog signaling and primary cilia are required for the formation of adult neural stem cells , 2008, Nature Neuroscience.
[18] J. Dick,et al. Comment on "Tumor Growth Need Not Be Driven by Rare Cancer Stem Cells" , 2007, Science.
[19] Monika Engelhardt,et al. Essential role of stromally induced hedgehog signaling in B-cell malignancies , 2007, Nature Medicine.
[20] C. Huff,et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma , 2007, Proceedings of the National Academy of Sciences.
[21] Gregory Y. Lauwers,et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis , 2003, Nature.
[22] Stephen B. Baylin,et al. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer , 2003, Nature.
[23] T. Holyoake,et al. Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. , 2007, Blood.
[24] P. N. Rao,et al. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification , 2001, Science.
[25] G. Daley,et al. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. , 1990, Science.
[26] G. Daley,et al. Mechanisms of Autoinhibition and STI-571/Imatinib Resistance Revealed by Mutagenesis of BCR-ABL , 2003, Cell.
[27] Tannishtha Reya,et al. Imaging hematopoietic precursor division in real time. , 2007, Cell stem cell.
[28] D. Baker,et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation , 2001, Nature Immunology.
[29] F. Lee,et al. Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice , 2006, Proceedings of the National Academy of Sciences.